MilliporeSigma Articles
-
Integrated Approach In Managing CPV And APQR
11/12/2024
Many companies continue to manually collect data. Utilizing digital technologies can greatly improve productivity and efficiency by enabling real-time monitoring and streamlining regulatory reporting.
-
The Key To Viral Vector Success
11/11/2024
Establishing a robust and scalable viral vector process requires a multidisciplinary approach that incorporates expertise in foundational science, analytics, and biomanufacturing.
-
Optimizing Safety Measures For rAAV Therapies
10/11/2024
Explore common process-related impurities found in recombinant Adeno-Associated Virus (rAAV) vectors and the analytical testing methods used for these residuals.
-
The Role Of Extractables Data In The Adoption Of Single-Use Systems
8/29/2024
Explore guidance for evaluating single-use systems for extractables and leachables, and learn how supplier-provided single-use system extractables data can save both time and resources.
-
Business Continuity Management: The Benzonase® Endonuclease Success Story
8/21/2024
Business continuity management is a key success contributor to the pharma industry. Explore best practices for a robust supply chain and how they can translate into success stories.
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
8/15/2024
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
Scaling Up The Learning Curve For Large-Scale AAV Manufacturing
7/26/2024
The complexity of manufacturing AAV products, coupled with the challenges linked to controlling their costs, underscore the importance of improving the efficiency and scalability of these processes.
-
Optimizing mRNA For Success: A Guide To Enhanced Stability, Delivery, And Efficacy
6/11/2024
RNA offers exciting potential for vaccines, gene therapies, and personalized medicine, but challenges related to stability, delivery, and manufacturing persist.
-
The Next Generation Of mRNA Products: Implications For Quality Control
5/30/2024
To fully realize the potential of mRNA as a therapeutic or vaccine modality, developers will need to employ cutting-edge analytical methods to ensure the safety and efficacy of these novel products.
-
Advancing A LNP Formulation To Clinical And Commercial Manufacturing
3/25/2024
Lipid selection impacts the final LNP drug product and the LNP process. Review critical quality considerations for lipids and the process requirements for successful commercial-scale manufacturing.